Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario
暂无分享,去创建一个
Piero Musiani | Federica Cavallo | Annalisa Astolfi | Manuela Iezzi | Raffaele A. Calogero | Patrizia Nanni | Guido Forni | Pier-Luigi Lollini | P. Musiani | P. Lollini | G. Forni | M. Iezzi | R. Calogero | P. Nanni | A. Astolfi | F. Cavallo | Elena Quaglino | Simona Rolla | E. Quaglino | Carla De Giovanni | S. Rolla | C. Giovanni
[1] Giovanni Parmigiani,et al. A Cross-Study Comparison of Gene Expression Studies for the Molecular Classification of Lung Cancer , 2004, Clinical Cancer Research.
[2] Y. Yarden,et al. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions , 1997, FEBS letters.
[3] S. Ostrand-Rosenberg,et al. Animal models of tumor immunity, immunotherapy and cancer vaccines. , 2004, Current opinion in immunology.
[4] Shuang Huang,et al. Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.
[5] P. Musiani,et al. Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice , 2001, Gene Therapy.
[6] Nir Friedman,et al. Practical approaches to analyzing results of microarray experiments. , 2002, American journal of respiratory cell and molecular biology.
[7] G. Forni,et al. Prophylactic cancer vaccines. , 2002, Current opinion in immunology.
[8] Piero Musiani,et al. Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine , 2004, Cancer Research.
[9] M. Gaestel,et al. P66ShcA interacts with MAPKAP kinase 2 and regulates its activity , 2004, FEBS letters.
[10] S. Ménard,et al. p185neu protein is required for tumor and anchorage‐independent growth, not for cell proliferation of transgenic mammary carcinoma , 2000, International journal of cancer.
[11] Piero Musiani,et al. DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2 , 2000, The Journal of Immunology.
[12] Zoltan Szallasi,et al. Increased measurement accuracy for sequence-verified microarray probes. , 2004, Physiological genomics.
[13] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[14] Richard Simon,et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] P. Musiani,et al. Toward a Long-Lasting Immune Prevention of HER2 Mammary Carcinomas: Directions from Transgenic Mice , 2004, Cell cycle.
[16] Piero Musiani,et al. Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice , 2001, The Journal of experimental medicine.
[17] O. Finn,et al. Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.
[18] J. Saxe,et al. The Blind Men and the Elephant , 1963 .
[19] N. Scrimshaw. The Blind Men and the Elephant , 1998 .
[20] M. C. Rudolph,et al. Functional Development of the Mammary Gland: Use of Expression Profiling and Trajectory Clustering to Reveal Changes in Gene Expression During Pregnancy, Lactation, and Involution , 2003, Journal of Mammary Gland Biology and Neoplasia.
[21] Piero Musiani,et al. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. , 2004, The Journal of clinical investigation.
[22] C. Schindler,et al. Activation of STAT Factors by Prolactin, Interferon-γ, Growth Hormones, and a Tyrosine Phosphatase Inhibitor in Rabbit Primary Mammary Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.
[23] H. Varmus,et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Kuwano,et al. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins. , 2003, Journal of immunology.
[25] Alan Ashworth,et al. Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.
[26] M. Kuwano,et al. Synergistic Effect of TNF-α in Soluble VCAM-1-Induced Angiogenesis Through α4 Integrins1 , 2003, The Journal of Immunology.
[27] Tom Freeman,et al. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression , 2003, Breast Cancer Research.
[28] N. Hynes,et al. The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.
[29] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] Seamus J. Martin,et al. Pro-apoptotic Proteins Released from the Mitochondria Regulate the Protein Composition and Caspase-processing Activity of the Native Apaf-1/Caspase-9 Apoptosome Complex* , 2004, Journal of Biological Chemistry.
[31] J. Rosen,et al. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice , 1995, Molecular and cellular biology.
[32] P. Musiani,et al. LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. , 2003, Cancer research.
[33] Y Sakaki,et al. The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2. , 1997, Genomics.
[34] M. Fitzgibbon,et al. Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export* , 2002, The Journal of Biological Chemistry.
[35] Philip R. Cohen,et al. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. , 1993, The Biochemical journal.
[36] B. McManus,et al. Overexpression of Interferon-γ-inducible GTPase Inhibits Coxsackievirus B3-induced Apoptosis through the Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway and Inhibition of Viral Replication* , 2003, Journal of Biological Chemistry.
[37] Piero Musiani,et al. Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice , 1998, The Journal of experimental medicine.
[38] G Vassart,et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.
[39] A. Sher,et al. The Function of Gamma Interferon-Inducible GTP-Binding Protein IGTP in Host Resistance to Toxoplasma gondii Is Stat1 Dependent and Requires Expression in Both Hematopoietic and Nonhematopoietic Cellular Compartments , 2002, Infection and Immunity.
[40] Piero Musiani,et al. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. , 2004, Cancer research.
[41] G. Forni,et al. Immunological inhibition of carcinogenesis , 2004, Cancer Immunology, Immunotherapy.